A Trial to Assess the Efficacy and Safety of OTR4132-MD in Patients with Acute Ischemic Stroke
- Conditions
- Endovascular ThrombectomyIschemic Cerebrovascular Accident
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2024-11-26
- Target Recruit Count
- 60
- Registration Number
- NCT06700824
- Locations
- 🇫🇷
Centre Hospitalier Universi-taire de Bordeaux-Hôpital Pellegrin, Bordeaux, France
🇫🇷Centre hospitalier universi-taire de Brest (Cavale Blanche), Brest, France
🇫🇷CHU Henri-Mondor, Créteil, France
CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa
- Conditions
- Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa, Junctional
- Interventions
- Device: CACIPLIQ20Drug: Placebo
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2024-02-13
- Target Recruit Count
- 16
- Registration Number
- NCT06007235
- Locations
- 🇫🇷
Hopital Necker - enfants malades, Paris, France
Post-surgical Scars After the Use of CACIPLIQ20
- Conditions
- Scars
- Interventions
- Device: CACIPLIQ20®Drug: Placebo (saline solution)
- First Posted Date
- 2022-09-06
- Last Posted Date
- 2024-02-13
- Target Recruit Count
- 50
- Registration Number
- NCT05528328
- Locations
- 🇫🇷
Clinique Turin, Paris, Ile De France, France
🇫🇷CHU Brest, Brest, Bretagne, France
MAtrix Therapy for Hard-to-heal ChrOnic Wounds
- Conditions
- Arterial UlcerDiabetic Foot UlcerChronic Ulcer of Leg or FootVenous Ulcer of Leg
- Interventions
- Device: CACIPLIQ20®
- First Posted Date
- 2021-12-28
- Last Posted Date
- 2023-11-01
- Target Recruit Count
- 200
- Registration Number
- NCT05170984
- Locations
- 🇫🇷
Réseau Cicat-Occitanie, Montpellier, France
An Open, Study to Assess the Safety of RGTA® (OTR4132) in Patients With Acute Ischemic Stroke (AIS)
- Conditions
- Stroke, Acute
- Interventions
- Device: OTR4132MD
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2024-08-02
- Target Recruit Count
- 19
- Registration Number
- NCT04083001
- Locations
- 🇫🇷
CHU Grenoble Alpes, Grenoble, Auvergne Rhône Alpes, France
🇫🇷CHU Nancy, Nancy, Grand Est, France
🇫🇷CHU Bordeaux Pellegrin, Bordeaux, Nouvelle Aquitaine, France
Efficacy of MUCIPLIQ on the Incidence of Radio-chemotherapy-induced Mucositis in Patients Suffering From Oral Cancer
- Conditions
- Carcinoma in Situ of Upper Respiratory TractOral Mucositis
- Interventions
- Device: MUCIPLIQDevice: Placebo
- First Posted Date
- 2013-04-25
- Last Posted Date
- 2016-05-05
- Target Recruit Count
- 136
- Registration Number
- NCT01840436
- Locations
- 🇫🇷
Centre de Cancérologie Léon Bérard, Lyon, France
🇫🇷CHRU de Besançon, Site du CH Belfort-Montbéliard, Montbéliard, France
🇫🇷APHP - Hôpital Tenon, Paris, Ile de France, France
Efficacy Of CACIPLIQ20 On Diabetic Ulcers In Patients Wearing An Nonremovable, Windowed, Fiberglass Cast Boot
- Conditions
- Foot UlcerDiabetes MellitusDiabetic Neuropathy
- Interventions
- Device: CACIPLIQ20 and Nonremovable, Windowed, Fiberglass Cast BootDevice: Placebo and Nonremovable, Windowed, Fiberglass Cast Boot
- First Posted Date
- 2011-11-18
- Last Posted Date
- 2014-04-09
- Target Recruit Count
- 20
- Registration Number
- NCT01474473
- Locations
- 🇫🇷
Pitié-Salpêtrière Hospital, Paris, France
Randomized Double Blinded Study Evaluating CACICOL20 Efficiency Versus Placebo Corneal Chronic Ulcers Healing
- Conditions
- Corneal Ulcer
- Interventions
- Device: PlaceboDevice: CACICOL20
- First Posted Date
- 2010-11-17
- Last Posted Date
- 2016-05-05
- Target Recruit Count
- 139
- Registration Number
- NCT01242839
- Locations
- 🇫🇷
Centre Hospitalier Universitaire Amiens, Amiens, France
🇫🇷Hôpital BICETRE, Le Kremlin-bicetre, France
🇫🇷CHU Angers, Angers, France